2021 Revenues ($USD) : $16,687,000,000
2021 R&D spend : not available
2021 Number of Employees : not available
Fiscal Year End : 6/30/2021
Key People : Scott Barnhart, president, global manufacturing and supply chain; Ben Brinker, president, international, medical segment; Steve C de Baca, EVP, quality and regulatory affairs; Craig Cowman, EVP, global sourcing; Victor Crawford, CEO, pharmaceutical segment; Suzanne Foster, president, Cardinal Health at-Home solutions; Michele Holcomb, EVP, chief strategy and business development officer; Jason Hollar, CFO; Heidi Hunter, president, specialty solutions; Mike Kaufmann, CEO; Steve Mason, CEO, medical segment; Jessica Mayer, chief legal and compliance officer; Mike Pintek, president, nuclear and precision health solutions; Robert Rajalingam, president, U.S. medical products and distribution; Brian Rice, EVP, chief information officer and global business services; Ola Snow, chief human resources officer; Debbie Weitzman, president, pharmaceutical distribution and The Medical Shoppe International; Sarah Wills, EVP, chief corporate affairs officer.

About the company: Headquartered in Dublin, Ohio and founded in 1979, Cardinal Health provides pharmaceuticals, medical products and supply chain efficiency solutions for the healthcare system. The goal is to connect patients, providers, payers, pharmacists and manufacturers for integrated care coordination and patient management. Cardinal Health has two segments: Pharmaceutical and Medical. Pharmaceutical distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the U.S. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products worldwide. It also distributes a broad range of medical, surgical and laboratory products known as national brand products and provides supply chain services and solutions to health providers in the U.S. and Canada — and distributes medical products to patients' homes in the U.S. through the Cardinal Health at-Home Solutions division. Major news in 2021 included the company completing the $1 billion sale of its Cordis business to private equity firm Hellman & Friedman. The deal took place six years after Cardinal Health bought Cordis and its minimally-invasive cardiovascular technology from J&J for nearly $2 billion. –JH